Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors
Insulin-like growth factors I and II (IGF-I and -II) are potent mitogens for various cancers, including carcinoma of the prostate. In several experimental cancers, treatment with antagonists of growth hormone-releasing hormone (GH-RH) produces a reduction in IGF-I and -II, concomitant to inhibition...
Збережено в:
| Опубліковано в:: | Proc Natl Acad Sci U S A |
|---|---|
| Автори: | , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
National Academy of Sciences
1998
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC21168/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9671770/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.95.15.8864 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|